Verges B, Duvillard L, Pais de Barros JP, Bouillet B, et al. Liraglutide Increases the Catabolism of Apolipoprotein B100-Containing
Lipoproteins in Patients With Type 2 Diabetes and Reduces Proprotein Convertase
Subtilisin/Kexin Type 9 Expression. Diabetes Care 2021 Feb 2. pii: dc20-1843. doi: 10.2337/dc20-1843.
PMID: 33531418